Inflammation & Allergy - Drug Targets (Discontinued)
Title:Acknowledgements to the Reviewers:
Volume: 13 Issue: 5
Export Options
About this article
Cite this article as:
Acknowledgements to the Reviewers:, Inflammation & Allergy - Drug Targets (Discontinued) 2014; 13 (5) . https://dx.doi.org/10.2174/187152811305150129161107
DOI https://dx.doi.org/10.2174/187152811305150129161107 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
Related Journals
Related Books
20
Related Articles
-
Neutrophil F-actin Dynamics in Familial Mediterranean Fever: The Unequal Effect of Colchicine on Activated Neutrophils
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Integrated Analysis of Transcriptomic and Proteomic Data
Current Genomics Cognitive Identity in Schizophrenia: Vision, Space, and Body Perception from Prodrome to Syndrome
Current Psychiatry Reviews Evolution of Resistance to Cancer Therapy
Current Pharmaceutical Design Editorial
Current Enzyme Inhibition Statin Therapy and New-onset Diabetes: Molecular Mechanisms and Clinical Relevance
Current Pharmaceutical Design Combined Treatment with PPAR-γ Agonists in Pancreatic Cancer: A Glimmer of Hope for Cancer Therapy?
Current Cancer Drug Targets Targeted Drug Delivery Across the Blood Brain Barrier in Alzheimer’s Disease
Current Pharmaceutical Design Development of an Optimized Protein Chip for the Detection of Fish Parvalbumin Allergen
Current Analytical Chemistry GPR55, a Lysophosphatidylinositol Receptor with Cannabinoid Sensitivity?
Current Topics in Medicinal Chemistry Medicinal Chemistry of 2,2,4-Substituted Morpholines
Current Medicinal Chemistry Natural Product as Substrates of ABC Transporters: A Review
Recent Patents on Anti-Cancer Drug Discovery Cholinergic Drugs as Therapeutic Tools in Inflammatory Diseases: Participation of Neuronal and Non-Neuronal Cholinergic Systems.
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Nanocoating of Diazoresin/Polysaccharides Multilayer Boosts Biocompatibility of Nitinol Biomedical Devices
Current Nanoscience Safety and Efficacy of Tocolytics for the Treatment of Spontaneous Preterm Labour
Current Pharmaceutical Design Strategies for Recruitment of Stem Cells to Treat Myocardial Infarction
Current Pharmaceutical Design Recommendations for Severe Hypertriglyceridemia Treatment, are there New Strategies?
Current Vascular Pharmacology Muscarinic Acetylcholine Receptors: New Potential Therapeutic Targets in Antinociception and in Cancer Therapy
Recent Patents on CNS Drug Discovery (Discontinued) The Hsp32 Inhibitors SMA-ZnPP and PEG-ZnPP Exert Major Growth-Inhibitory Effects on CD34+/CD38+ and CD34+/CD38- AML Progenitor Cells
Current Cancer Drug Targets Candidate Biomarkers for Fatigue in Systemic Lupus Erythematosus: A Critical Review
Current Rheumatology Reviews